Palliative Urinary Diversion for Malignant Ureteral Obstruction

Abstract
An analysis of 62 palliative urinary diversions for malignant ureteral obstruction is presented. The average postoperative survival was 187 days. Cell type, duration of known disease, tumor grade and stage, renal function and previous therapy did not strongly influence survival. Renal function returned to normal in 64% of the azotemic patients. Morbidity and mortality rates were high, largely because of underlying disease and adjuvant therapy. Nearly 2/3 of the patients left the hospital, and this group subsequently spent 84% of their remaining survival time at home. A criterion is presented for patient selection, and suggestions are made for the selection of an operative procedure.